An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein

被引:196
作者
Madani, N [1 ]
Kabat, D [1 ]
机构
[1] Oregon Hlth Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA
关键词
D O I
10.1128/JVI.72.12.10251-10255.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The vif gene of human immunodeficiency virus type 1 (HIV-1) encodes a basic M-r 23,000 protein that is necessary for production of infectious virions by nonpermissive cells (human lymphocytes and macrophages) but not by permissive cells such as HeLa-CD4. It had been proposed that permissive cells may contain an unidentified factor that functions like the viral Vif protein. To test this hypothesis, we produced pseudotyped wild-type and vif-deleted HIV gpt virions (which contain the HIV-1 genome with the bacterial mycophenolic acid resistance gene gpt in place of the viral env gene) in permissive cells, and we used them to generate nonpermissive H9 leukemic T cells that express these proviruses. We then fused these H9 cells with permissive HeLa cells that express the HIV-1 envelope glycoprotein gp120-gp41, and we asked whether the heterokaryons would release infectious HIV gpt virions. The results clearly showed that the vif-deleted virions released by the heterokaryons were noninfectious whereas the wild-type virions were highly infectious. This strongly suggests that nonpermissive cells, the natural targets of HIV-1, contain a potent endogenous inhibitor of HIV-I replication that is overcome by Vif.
引用
收藏
页码:10251 / 10255
页数:5
相关论文
共 28 条
  • [1] Ausubel FM., 1994, Curr. Protoc. Mol. Biol
  • [2] TRANSCOMPLEMENTATION OF VIF- HIV-1 MUTANTS IN CEM CELLS SUGGESTS THAT VIF AFFECTS LATE STEPS OF THE VIRAL LIFE-CYCLE
    BLANC, D
    PATIENCE, C
    SCHULZ, TF
    WEISS, R
    SPIRE, B
    [J]. VIROLOGY, 1993, 193 (01) : 186 - 192
  • [3] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF(-) MUTANT PARTICLES FROM RESTRICTIVE CELLS - ROLE OF VIF IN CORRECT PARTICLE ASSEMBLY AND INFECTIVITY
    BORMAN, AM
    QUILLENT, C
    CHARNEAU, P
    DAUGUET, C
    CLAVEL, F
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (04) : 2058 - 2067
  • [4] Phenotypically Vif(-) human immunodeficiency virus type 1 is produced by chronically infected restrictive cells
    Bouyac, M
    Rey, F
    Nascimbeni, M
    Courcoul, M
    Sire, J
    Blanc, D
    Clavel, F
    Vigne, R
    Spire, B
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (03) : 2473 - 2477
  • [5] CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef
    Chen, BK
    Gandhi, RT
    Baltimore, D
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (09) : 6044 - 6053
  • [6] HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes
    Collins, KL
    Chen, BK
    Kalams, SA
    Walker, BD
    Baltimore, D
    [J]. NATURE, 1998, 391 (6665) : 397 - 401
  • [7] PERIPHERAL-BLOOD MONONUCLEAR-CELLS PRODUCE NORMAL AMOUNTS OF DEFECTIVE VIF(-) HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PARTICLES WHICH ARE RESTRICTED FOR THE PRERETROTRANSCRIPTION STEPS
    COURCOUL, M
    PATIENCE, C
    REY, F
    BLANC, D
    HARMACHE, A
    SIRE, J
    VIGNE, R
    SPIRE, B
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (04) : 2068 - 2074
  • [8] Human immunodeficiency virus type 1 Vif does not influence expression or virion incorporation of gag-, pol-, and env-encoded proteins
    Fouchier, RAM
    Simon, JHM
    Jaffe, AB
    Malim, MH
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (12) : 8263 - 8269
  • [9] ROLE OF VIF IN REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN CD4+ T LYMPHOCYTES
    GABUZDA, DH
    LAWRENCE, K
    LANGHOFF, E
    TERWILLIGER, E
    DORFMAN, T
    HASELTINE, WA
    SODROSKI, J
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (11) : 6489 - 6495
  • [10] Infected cell protein (ICP)47 enhances herpes simplex virus neurovirulence by blocking the CD8+ T cell response
    Goldsmith, K
    Chen, W
    Johnson, DC
    Hendricks, RL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (03) : 341 - 348